Zehranur Tosunoğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zehranur Tosunoğlu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Esra Arslan
Department of Nuclear Medicine, University of Health Sciences Turkey, Istanbul Training and Research Hospital, 34098 Istanbul, Turkey
7 shared publications - Göksel Alçın
University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye
5 shared publications - Tevfik Fikret Çermik
University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye
4 shared publications - Ahmet Ertuğrul Öztürk
Clinic of Nuclear Medicine, University of Health Sciences, Istanbul Training and Research Hospital
3 shared publications - Elife Akgün
Department of Nuclear Medicine, University of Health Sciences Türkiye, Istanbul Training and Research Hospital, İstanbul, Türkiye
3 shared publications Esra Arslan
University of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye
3 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Mersin University in Molecular Oncologic Imaging
- Vol. 6 (2)
Isolated Primary B-Cell Lymphoma of the Larynx Mimicking Carcinoma: 18F-FDG PET/CT Findings
Primary laryngeal lymphoma is an extremely rare extranodal manifestation of non-Hodgkin lymphoma, accounting for less than 1% of all laryngeal neoplasms. We report a case of isolated primary B-cell lymphoma of the larynx evaluated with 18F-FDG PET/CT imaging. PET/CT demonstrated intense FDG uptake (SUVmax: 16.3) in the laryngeal lesion, while mild FDG uptake (SUVmax: 5.5) was observed in the right palatine tonsil, likely of inflammatory origin. The patient underwent R-CHOP therapy, and both interim and post-treatment PET/CT scans showed complete metabolic and anatomic response. This case highlights the critical role of 18F-FDG PET/CT in the staging and management of rare primary laryngeal lymphomas.
- 30 July 2026
- Published by Mersin University in Molecular Oncologic Imaging
- Vol. 6 (2)
Open AccessIsolated Primary B-Cell Lymphoma of the Larynx Mimicking Carcinoma: 18F-FDG PET/CT Findings
Primary laryngeal lymphoma is an extremely rare extranodal manifestation of non-Hodgkin lymphoma, accounting for less than 1% of all laryngeal neoplasms. We report a case of isolated primary B-cell lymphoma of the larynx evaluated with 18F-FDG PET/CT imaging. PET/CT demonstrated intense FDG uptake (SUVmax: 16.3) in the laryngeal lesion, while mild FDG uptake (SUVmax: 5.5) was observed in the right palatine tonsil, likely of inflammatory origin. The patient underwent R-CHOP therapy, and both interim and post-treatment PET/CT scans showed complete metabolic and anatomic response. This case highlights the critical role of 18F-FDG PET/CT in the staging and management of rare primary laryngeal lymphomas.
- 18 June 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (9) , e759-e767
Clinical Value of 68Ga-DOTA-Bombesin PET/CT Compared With 18F-FDG PET/CT in the Staging of Breast Cancer
Aim: To prospectively evaluate the diagnostic performance of 68 Ga-DOTA-Bombesin PET/CT compared with 18 F-FDG PET/CT in breast cancer (BC), emphasizing its utility across molecular subtypes and nodal staging. Patients and Methods: Twenty-four patients with biopsy-proven BC who underwent both 68 Ga-DOTA-Bombesin and 18 F-FDG PET/CT were included. Imaging findings were analyzed on a per-lesion and per-patient basis for primary tumor detection, axillary lymph-node involvement, and distant metastases. Quantitative parameters (SUVmax, MTV, and tumor-to-background ratios) were compared across histopathologic and receptor subgroups, with histopathology as the reference standard. Results: 68 Ga-DOTA-Bombesin visualized 92.3% of primary tumors, achieving comparable sensitivity to 18 F-FDG (84.6%) but higher specificity in nodal staging (100% vs. 53.8%). Bombesin uptake correlated strongly with estrogen receptor positivity and a lower Ki-67 index ( P 68 Ga-DOTA-Bombesin PET/CT provides a receptor-specific imaging approach in BC, showing complementary strengths to 18 F-FDG, particularly in hormone-receptor–positive and low-proliferation tumors. Its superior nodal specificity and theranostic potential support further evaluation of GRPR-targeted imaging and therapy in personalized BC management.
- 18 June 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (9) , e759-e767
Clinical Value of 68Ga-DOTA-Bombesin PET/CT Compared With 18F-FDG PET/CT in the Staging of Breast Cancer
Aim: To prospectively evaluate the diagnostic performance of 68 Ga-DOTA-Bombesin PET/CT compared with 18 F-FDG PET/CT in breast cancer (BC), emphasizing its utility across molecular subtypes and nodal staging. Patients and Methods: Twenty-four patients with biopsy-proven BC who underwent both 68 Ga-DOTA-Bombesin and 18 F-FDG PET/CT were included. Imaging findings were analyzed on a per-lesion and per-patient basis for primary tumor detection, axillary lymph-node involvement, and distant metastases. Quantitative parameters (SUVmax, MTV, and tumor-to-background ratios) were compared across histopathologic and receptor subgroups, with histopathology as the reference standard. Results: 68 Ga-DOTA-Bombesin visualized 92.3% of primary tumors, achieving comparable sensitivity to 18 F-FDG (84.6%) but higher specificity in nodal staging (100% vs. 53.8%). Bombesin uptake correlated strongly with estrogen receptor positivity and a lower Ki-67 index ( P 68 Ga-DOTA-Bombesin PET/CT provides a receptor-specific imaging approach in BC, showing complementary strengths to 18 F-FDG, particularly in hormone-receptor–positive and low-proliferation tumors. Its superior nodal specificity and theranostic potential support further evaluation of GRPR-targeted imaging and therapy in personalized BC management.
- 24 March 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (7) , e422-e430
Diagnostic Performance of 68Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions
Objective: This prospective study evaluated the diagnostic performance of 68 Ga DOTA-Pentixafor PET/CT in characterizing the functional properties and lateralization of aldosterone-producing and cortisol-producing adrenal cortical lesions. The contribution of Pentixafor PET/CT to diagnosis and treatment planning was assessed in comparison with CT, MRI, and 18 F-FDG PET/CT. Patients and Methods: Twenty-five patients with suspected benign functional adrenal cortical masses were included. All patients underwent whole-body imaging at 1 hour and delayed abdominal imaging at 2 hours following intravenous administration of 18 F-FDG and 68 Ga DOTA-Pentixafor. Lesion SUVmax, LCRSUVmax, and LLRSUVmax values were analyzed and correlated with laboratory parameters, other imaging modalities, and postoperative clinical and pathologic outcomes. Results: 68 Ga DOTA-Pentixafor PET/CT demonstrated distinct focal uptake relative to the contralateral adrenal gland and liver parenchyma in 6/6 (100%) patients with suspected PA, 5/18 (27.7%) with suspected CS, and 1/1 (100%) with suspected EAS. Among patients with focal uptake who underwent surgery, all PA (5/5) and all CS (5/5) cases were confirmed as adrenocortical adenomas, resulting in no false-positive findings (PPV 100%). However, due to 2 false-negative CS cases, pentixafor PET/CT demonstrated an overall sensitivity of 83.3%, specificity of 100%, and accuracy of 85.7%. Thresholds of SUVmax >15.11, LCRSUVmax >1.74, and LLRSUVmax >4.36 yielded sensitivities of 33.3%, 41.7%, and 41.7%, respectively, while maintaining 100% specificity. Clinical and biochemical improvement was observed in 100% (5/5) of operated PA patients and 100% (5/5) of operated CS patients. Follow-up of nonoperated patients is ongoing. Conclusion: 68 Ga DOTA-Pentixafor PET/CT is a valuable diagnostic and potentially therapeutic tool for benign functional adrenal cortical disorders such as PA, CS, and EAS, with the potential to establish a new standard in minimally invasive patient management.
- 24 March 2026
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (7) , e422-e430
Diagnostic Performance of 68Ga DOTA-Pentixafor PET/CT in Benign Functional Adrenal Cortical Lesions
Objective: This prospective study evaluated the diagnostic performance of 68 Ga DOTA-Pentixafor PET/CT in characterizing the functional properties and lateralization of aldosterone-producing and cortisol-producing adrenal cortical lesions. The contribution of Pentixafor PET/CT to diagnosis and treatment planning was assessed in comparison with CT, MRI, and 18 F-FDG PET/CT. Patients and Methods: Twenty-five patients with suspected benign functional adrenal cortical masses were included. All patients underwent whole-body imaging at 1 hour and delayed abdominal imaging at 2 hours following intravenous administration of 18 F-FDG and 68 Ga DOTA-Pentixafor. Lesion SUVmax, LCRSUVmax, and LLRSUVmax values were analyzed and correlated with laboratory parameters, other imaging modalities, and postoperative clinical and pathologic outcomes. Results: 68 Ga DOTA-Pentixafor PET/CT demonstrated distinct focal uptake relative to the contralateral adrenal gland and liver parenchyma in 6/6 (100%) patients with suspected PA, 5/18 (27.7%) with suspected CS, and 1/1 (100%) with suspected EAS. Among patients with focal uptake who underwent surgery, all PA (5/5) and all CS (5/5) cases were confirmed as adrenocortical adenomas, resulting in no false-positive findings (PPV 100%). However, due to 2 false-negative CS cases, pentixafor PET/CT demonstrated an overall sensitivity of 83.3%, specificity of 100%, and accuracy of 85.7%. Thresholds of SUVmax >15.11, LCRSUVmax >1.74, and LLRSUVmax >4.36 yielded sensitivities of 33.3%, 41.7%, and 41.7%, respectively, while maintaining 100% specificity. Clinical and biochemical improvement was observed in 100% (5/5) of operated PA patients and 100% (5/5) of operated CS patients. Follow-up of nonoperated patients is ongoing. Conclusion: 68 Ga DOTA-Pentixafor PET/CT is a valuable diagnostic and potentially therapeutic tool for benign functional adrenal cortical disorders such as PA, CS, and EAS, with the potential to establish a new standard in minimally invasive patient management.
- Open Access
- 23 March 2026
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
Multimodal Functional Imaging in Tumor-induced Osteomalacia: 68Ga-DOTATATE, 18F-FDG, and 68Ga-FAPI PET/CT Findings
Multimodal Functional Imaging in Tumor-induced Osteomalacia: 68Ga-DOTATATE, 18F-FDG, and 68Ga-FAPI PET/CT Findings - Molecular Imaging and Radionuclide Therapy
- 23 March 2026
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
Open AccessMultimodal Functional Imaging in Tumor-induced Osteomalacia: 68Ga-DOTATATE, 18F-FDG, and 68Ga-FAPI PET/CT Findings
Multimodal Functional Imaging in Tumor-induced Osteomalacia: 68Ga-DOTATATE, 18F-FDG, and 68Ga-FAPI PET/CT Findings - Molecular Imaging and Radionuclide Therapy
- Open Access
- 9 January 2026
- Published by Mersin University in Molecular Oncologic Imaging
- No. 1,p. 1-3
Incidental Detection of FDG-Avid Pulmonary Lesion on PET/CT in a Patient Referred for Hepatic Lesion Evaluation: Chronic Granulomatous Disease Mimicking Malignancy
We would like to report a patient referred for 18F-FDG PET/CT imaging for the evaluation of a non-FDG-avid liver lesion. However, an incidental FDG-avid lesion was determined in the posterobasal segment of the right lung. Subsequent biopsy of the pulmonary lesion revealed chronic granulomatous inflammation. This case highlights the importance of whole-body imaging in detecting unexpected clinically significant findings and highlights the role of PET/CT in identifying infectious or inflammatory processes beyond oncologic indications.
- 9 January 2026
- Published by Mersin University in Molecular Oncologic Imaging
- No. 1,p. 1-3
Open AccessIncidental Detection of FDG-Avid Pulmonary Lesion on PET/CT in a Patient Referred for Hepatic Lesion Evaluation: Chronic Granulomatous Disease Mimicking Malignancy
We would like to report a patient referred for 18F-FDG PET/CT imaging for the evaluation of a non-FDG-avid liver lesion. However, an incidental FDG-avid lesion was determined in the posterobasal segment of the right lung. Subsequent biopsy of the pulmonary lesion revealed chronic granulomatous inflammation. This case highlights the importance of whole-body imaging in detecting unexpected clinically significant findings and highlights the role of PET/CT in identifying infectious or inflammatory processes beyond oncologic indications.
- Open Access
- 9 January 2026
- Published by Mersin University in Molecular Oncologic Imaging
- No. 1,p. 4-9
Dedifferentiated Liposarcoma: Two Case Reports of Retroperitoneal and Paratesticular Presentations with FDG PET/CT Findings
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive soft tissue sarcoma most commonly arising in the retroperitoneum, but it can also occur in uncommon sites such as the paratesticular region. We present two cases of DDLPS with distinct clinical presentations and highlight the diagnostic and prognostic utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). The first case describes a retroperitoneal DDLPS in a female patient with intense FDG uptake. In contrast, the second case presents a paratesticular DDLPS in a male patient with recurrence and metastatic progression on PET/CT imaging despite chemoradiotherapy. These cases emphasize the role of FDG PET/CT in staging and biopsy guidance and in monitoring treatment response and prognosis.
- 9 January 2026
- Published by Mersin University in Molecular Oncologic Imaging
- No. 1,p. 4-9
Open AccessDedifferentiated Liposarcoma: Two Case Reports of Retroperitoneal and Paratesticular Presentations with FDG PET/CT Findings
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive soft tissue sarcoma most commonly arising in the retroperitoneum, but it can also occur in uncommon sites such as the paratesticular region. We present two cases of DDLPS with distinct clinical presentations and highlight the diagnostic and prognostic utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). The first case describes a retroperitoneal DDLPS in a female patient with intense FDG uptake. In contrast, the second case presents a paratesticular DDLPS in a male patient with recurrence and metastatic progression on PET/CT imaging despite chemoradiotherapy. These cases emphasize the role of FDG PET/CT in staging and biopsy guidance and in monitoring treatment response and prognosis.
- Open Access
- 1 August 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 34 (3) , 249-251
Rare Acute Polyarticular Gout Disease Detected with 18F-FDG PET/CT
Undefined - Molecular Imaging and Radionuclide Therapy
- 1 August 2025
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 34 (3) , 249-251
Open AccessRare Acute Polyarticular Gout Disease Detected with 18F-FDG PET/CT
Undefined - Molecular Imaging and Radionuclide Therapy
- 25 September 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (11) , e583-e584
18F-FDG PET/CT Imaging Findings in Adult-Onset Rasmussen Encephalitis
Rasmussen encephalitis is a rare condition characterized by chronic, progressive encephalitis. Typically, it involves one cerebral hemisphere and manifests through intractable epileptic seizures. Its occurrence in adults is notably infrequent. In this case, we presented the observations from an 18F-FDG PET/CT scan of a 70-year-old man diagnosed with Rasmussen encephalitis, where MRI displayed nonspecific findings.
- 25 September 2024
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 49 (11) , e583-e584
18F-FDG PET/CT Imaging Findings in Adult-Onset Rasmussen Encephalitis
Rasmussen encephalitis is a rare condition characterized by chronic, progressive encephalitis. Typically, it involves one cerebral hemisphere and manifests through intractable epileptic seizures. Its occurrence in adults is notably infrequent. In this case, we presented the observations from an 18F-FDG PET/CT scan of a 70-year-old man diagnosed with Rasmussen encephalitis, where MRI displayed nonspecific findings.
- Open Access
- 23 February 2024
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 33 (1) , 47-49
Detection of Rare Gallbladder Microperforation by 18F-FDG PET/CT in a Patient with Maxillary Sinus Cancer
Gallbladder perforation is one of the most serious complications of cholecystitis and is rarely seen in 2-11% of cases. Pericholecystic abscesses secondary to gallbladder perforation are rare. Rapid diagnosis is important because of high morbidity and mortalityrates. A subcapsular abscess secondary to gallbladder microperforation is presented on 18F-fluorodeoxyglucose positron emission tomography/computed tomography performed for restaging in a patient with maxillary sinus cancer.
- 23 February 2024
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 33 (1) , 47-49
Open AccessDetection of Rare Gallbladder Microperforation by 18F-FDG PET/CT in a Patient with Maxillary Sinus Cancer
Gallbladder perforation is one of the most serious complications of cholecystitis and is rarely seen in 2-11% of cases. Pericholecystic abscesses secondary to gallbladder perforation are rare. Rapid diagnosis is important because of high morbidity and mortalityrates. A subcapsular abscess secondary to gallbladder microperforation is presented on 18F-fluorodeoxyglucose positron emission tomography/computed tomography performed for restaging in a patient with maxillary sinus cancer.
- Open Access
- 9 February 2024
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 33 (3) , 182-184
18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma
Paragangliomas (PGLs) are neuroendocrine tumors originating from the neural crest. They usually arise from the adrenal medulla and sympathetic or parasympathetic ganglions. Approximately 10% of PGLs are located in the extra-adrenal gland. Renal PGL is a rare condition. In this case report, we present the18F-fluorodeoxyglucose 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and 68 Ga-DOTATATE PET/CT findings of polycystic kidney-derived PGL.
- 9 February 2024
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 33 (3) , 182-184
Open Access18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma
Paragangliomas (PGLs) are neuroendocrine tumors originating from the neural crest. They usually arise from the adrenal medulla and sympathetic or parasympathetic ganglions. Approximately 10% of PGLs are located in the extra-adrenal gland. Renal PGL is a rare condition. In this case report, we present the18F-fluorodeoxyglucose 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and 68 Ga-DOTATATE PET/CT findings of polycystic kidney-derived PGL.